Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Twitter Summary: FDA approves Trulicity for #T2D, 1 st ready-to-use once-weekly GLP-1 agonist in the US, with a patient-friendly “auto-injector” – launch for later this...
Twitter summary: After huge anticipation for this innovative drug combination, Novo Nordisk’s Xultophy received approval in Europe for #T2D, 1 st ever basal insulin/GLP-...
Twitter summary: Lilly’s new basal #insulin Peglispro superior to Sanofi’s Lantus in A1c reduction, though some potential liver safety and hypo concerns On September 4,...
Twitter summary: New Bydureon pen launched in US – more user-friendly “twist, tap, twist” procedure simplifies the injection process AstraZeneca recently launched its...
Twitter summary: BI/Lilly’s #insulin glargine receives EU approval – “Abrasia” set to launch in mid-2015 as 1 st ever “biosimilar” insulin in Europe On September 10, Eli...
Twitter summary: BI/Lilly launch Jardiance in the US, making it the 3 rd SGLT-2 inhibitor on the market; savings program for one-year free supply After its recent FDA...
Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...
Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...
Twitter summary: FDA approves first-ever SGLT-2 inhibitor/metformin combo pill in the US – Janssens’s Invokamet launched Aug 18 On August 8, Janssen announced the FDA...
Twitter summary: New Sanofi & MannKind partnership to bring inhaled insulin Afrezza to US in early 2015, presumably primarily to type 2 patients to start On August...
Twitter summary: FDA grants “tentative approval” to Lilly/BI’s Basaglar – new insulin option will be an alternative to Lantus in future On August 18, Eli Lilly and...
How many different factors can affect blood glucose? See the 22 things that can change your blood sugar in the short-term...
Twitter Summary: Novo Nordisk’s Xultophy gets positive recommendation in Europe, full approval to hopefully come soon! On July 25, Novo Nordisk announced that the...
Twitter summary: Using a #T2D therapy for #T1D, Lexicon & JDRF partner up for phase 2 trial of SGLT-2/SGLT-1 dual inhibitor drug On July 9, Lexicon announced a...
Twitter summary: FDA approves Jardiance as third SGLT-2 inhibitor for #T2D, joins Invokana and Farxiga and potential future for #T1D On August 1, the FDA announced...
Can a type 2 diabetes drug work for type 1? Will an experimental drug improve blood glucose and body weight?
Expert Dr. Irl Hirsch’s eight tips for managing diabetes on a budget.
We’ve been following the development of Lilly’s Trulicity (dulaglutide), a once-weekly GLP-1 receptor agonist , for almost two years now, so it was encouraging to hear...
On June 19, Novo Nordisk announced the launch of its FlexTouch pen for the long-acting basal insulin Levemir (insulin detemir). FlexTouch, which has been approved in...
Advances in type 1 diabetes at The American Diabetes Association 74th Scientific Sessions

Pages